Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$708.84 - $794.68 $30.3 Million - $33.9 Million
-42,679 Closed
0 $0
Q2 2021

Aug 17, 2021

SELL
$576.64 - $649.04 $4.81 Million - $5.42 Million
-8,344 Reduced 16.35%
42,679 $27.5 Million
Q1 2021

May 17, 2021

SELL
$547.01 - $662.35 $13.1 Million - $15.9 Million
-23,977 Reduced 31.97%
51,023 $29.1 Million
Q4 2020

Mar 05, 2021

SELL
$510.68 - $643.45 $7.66 Million - $9.65 Million
-15,000 Reduced 16.67%
75,000 $43.7 Million
Q3 2020

Nov 16, 2020

BUY
$454.43 - $535.6 $2.27 Million - $2.68 Million
5,000 Added 5.88%
90,000 $46.4 Million
Q2 2020

Aug 10, 2020

SELL
$334.87 - $493.06 $16.7 Million - $24.7 Million
-50,000 Reduced 37.04%
85,000 $38.4 Million
Q1 2020

Jun 04, 2020

SELL
$320.01 - $409.07 $9.08 Million - $11.6 Million
-28,379 Reduced 17.37%
135,000 $47.3 Million
Q4 2019

Feb 12, 2020

SELL
$319.73 - $374.2 $8.51 Million - $9.96 Million
-26,621 Reduced 14.01%
163,379 $60.5 Million
Q3 2019

Nov 14, 2019

SELL
$304.55 - $345.24 $3.05 Million - $3.45 Million
-10,000 Reduced 5.0%
190,000 $63.2 Million
Q2 2019

Aug 14, 2019

BUY
$286.93 - $312.59 $3.38 Million - $3.69 Million
11,795 Added 6.27%
200,000 $62.5 Million
Q1 2019

May 13, 2019

SELL
$224.3 - $317.41 $8.25 Million - $11.7 Million
-36,795 Reduced 16.35%
188,205 $57.5 Million
Q4 2018

Feb 13, 2019

BUY
$220.1 - $309.0 $49.5 Million - $69.5 Million
225,000 New
225,000 $52.2 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.15B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Tower House Partners LLP Portfolio

Follow Tower House Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower House Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Tower House Partners LLP with notifications on news.